Radiotherapy Combined With Irinotecan and Apatinib Followed by PD-1 Antibody and Apatinib for Advanced Solid Tumors

Conditions

• Solid Tumor

Interventions

• RADIATION: radiotherapy
• DRUG: irinotecan liposome
• DRUG: apatinib
• DRUG: PD-1 antibody

Sponsor

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School